beta-lapachone has been researched along with Hyperplasia in 2 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SY | 1 |
| Jeoung, NH | 1 |
| Oh, CJ | 1 |
| Choi, YK | 1 |
| Lee, HJ | 1 |
| Kim, HJ | 1 |
| Kim, JY | 1 |
| Hwang, JH | 1 |
| Tadi, S | 1 |
| Yim, YH | 1 |
| Lee, KU | 1 |
| Park, KG | 1 |
| Huh, S | 1 |
| Min, KN | 1 |
| Jeong, KH | 1 |
| Park, MG | 1 |
| Kwak, TH | 1 |
| Kweon, GR | 1 |
| Inukai, K | 1 |
| Shong, M | 1 |
| Lee, IK | 1 |
| Calvert, PA | 1 |
| Bennett, MR | 1 |
2 other studies available for beta-lapachone and Hyperplasia
| Article | Year |
|---|---|
Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals | 2009 |
Restenosis revisited.
Topics: Animals; Cardiovascular Agents; Carotid Stenosis; Cell Proliferation; Coronary Restenosis; Drug-Elut | 2009 |